Our representatives attended the Vaccine Innovation Forum World 2026 in Shanghai on 11-14 March 2026. A gathering that convened global vaccine leaders, policymakers, scientists, and industry partners to review the latest progress in vaccine platforms.
Keynotes addressed modular production technologies, new adjuvant systems, and strategies for rapid scale‑up.
Topics included novel platforms (mRNA, viral vectors), manufacturing flexibility, regulatory alignment, and strategies for equitable rollout in low‑ and middle‑income.
This event is emphasising partnerships that accelerate trials without compromising safety. Exhibits featured analytics tools, cold‑chain solutions, and pilot projects for joint clinical studies underscoring the forum’s role as a catalyst for cross‑border research collaboration.
